Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
Open accessThe DOI matches its Crossref record; 153 of the 156 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in the community, as well as treatment failure, relapse, and development or amplification of drug resistance. We conducted a systematic review and meta-analysis of adherence interventions, including directly observed therapy (DOT), to determine which approaches lead to improved TB treatment outcomes. METHODS AND FINDINGS: We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retrospective cohort studies (CSs) with an internal or external control group that evaluated any adherence intervention and conducted a meta-analysis of their impact on TB treatment outcomes. Our search identified 7,729 articles, of which 129 met the inclusion criteria for quantitative analysis. Seven adherence categories were identified, including DOT offered by different providers and at various locations, reminders and tracers, incentives and enablers, patient education, digital technologies (short message services [SMSs] via mobile phones and video-observed therapy [VOT]), staff education, and combinations of these interventions. When compared with DOT alone, self-administered therapy (SAT) was associated with lower rates of treatment success (CS: risk ratio [RR] 0.81, 95% CI 0.73-0.89; RCT: RR 0.94, 95% CI 0.89-0.98), adherence (CS: RR 0.83, 95% CI 0.75-0.93), and sputum smear conversion (RCT: RR 0.92, 95% CI 0.87-0.98) as well as higher rates of development of drug resistance (CS: RR 4.19, 95% CI 2.34-7.49). When compared to DOT provided by healthcare providers, DOT provided by family members was associated with a lower rate of adherence (CS: RR 0.86, 95% CI 0.79-0.94). DOT delivery in the community versus at the clinic was associated with a higher rate of treatment success (CS: RR 1.08, 95% CI 1.01-1.15) and sputum conversion at the end of two months (CS: RR 1.05, 95% CI 1.02-1.08) as well as lower rates of treatment failure (CS: RR 0.56, 95% CI 0.33-0.95) and loss to follow-up (CS: RR 0.63, 95% CI 0.40-0.98). Medication monitors improved adherence and treatment success and VOT was comparable with DOT. SMS reminders led to a higher treatment completion rate in one RCT and were associated with higher rates of cure and sputum conversion when used in combination with medication monitors. TB treatment outcomes improved when patient education, healthcare provider education, incentives and enablers, psychological interventions, reminders and tracers, or mobile digital technologies were employed. Our findings are limited by the heterogeneity of the included studies and lack of standardized research methodology on adherence interventions. CONCLUSION: TB treatment outcomes are improved with the use of adherence interventions, such as patient education and counseling, incentives and enablers, psychological interventions, reminders and tracers, and digital health technologies. Trained healthcare providers as well as community delivery provides patient-centered DOT options that both enhance adherence and improve treatment outcomes as compared to unsupervised, SAT alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



























Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The consequences of poor adherence include delayed sputum culture conversion, treatment failure, relapse, prolonged infectiousness, development of drug resistance, and increased morbidity and mortality [4,5].”
From Psychosocial Interventions for Improving Treatment Adherence in Tuberculosis Patients: A Scoping Review of Evidence-Based Approaches. (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies)47, 48 and social protection interventions (eg, cash transfers and economic incentives)49, 50 can increase treatment adherence and prevent mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2014) · Medical Entomology and Zoology · Cited by 17,633
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766 · cited 1×
“Psychological interventions aim to support via psychological or emotional counseling or a social network of peers undergoing TB treatment as a means of improving adherence to TB treatment [18,19].”
BackgroundNahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Self-citationPatient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Assessing the Gold Standard — Lessons from the History of RCTs
Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmms1604593 · Cited by 664
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589 · cited 2×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundResultOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Research works printed but not linked: 7
- Alipanah N, Jarlsberg L, Miller C, Lechner A, Wai K, Nahid P. Report for Systematic Review for Adherence Interventions in TB Treatment. World Health Organization guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017;Annex 5.
- Review Manager (RevMan). 5.3 ed Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration; 2014.
- Vieira AA, Ribeiro SA. Compliance with tuberculosis treatment after the implementation of the directly observed treatment, short-course strategy in the city of Carapicuiba, Brazil. J Bras Pneumol. 2011; 37(2): 223– 31. Epub 2011/05/04.. 21537659
- Arora VK S N.; Gupta R. Community mediated domiciliary DOTS execution—A study from New Delhi. Ind J Tub. 2003; 50: 143– 50.
- Cantalice Filho JP. Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes. J Bras Pneumol. 2009; 35(10): 992– 7. Epub 2009/11/18.. 19918632
- Paramasivan RP, R. T.; Rajasekaran S. Short course chemotherapy: A controlled study of indirect default retrieval method. Ind J Tub. 1993; 40: 185– 90.
- A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis. 1997; 1(6): 509– 17. Epub 1998/03/06.. 9487448
Cited by
Items 301–400 of 503
Bin Qamar, R. A., Pereira, H., & Alckmin-Carvalho, F. (2026) · Advances in respiratory medicine · doi:10.3390/arm94030032 · Cited by 1
“The consequences of poor adherence include delayed sputum culture conversion, treatment failure, relapse, prolonged infectiousness, development of drug resistance, and increased morbidity and mortality [4,5].”
Update on drug-resistant pulmonary tuberculosis treatment in hemodialysis patients
Jonny, J., Saraswati, P. D., Ramadhani, B. P., Sitepu, E. C., & Pasiak, T. F. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.04.011 · Cited by 1
Коломиец, В. М., Коваленко, А. Л., Pavlenko, E. P., Petrov, A. Y., & Таликова, Е. В. (2024) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2023-68-9-10-79-84 · Cited by 1
Assessment of Patient Medication Adherence Using Digital Health Technologies: A Research
Hoval, T., & Nevase, S. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.60289 · Cited by 4
Xianyu, F., Huang, Y., Guo, S., & Chongsuvivatwong, V. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9050119 · Cited by 1
“Consistently adhering to the prescribed medication regimen over the long term can effectively prevent the development of drug-resistant strains of MTB, ensuring the smooth progression of the treatment course [24,25].”
BackgroundHigh rates of unfavourable TB treatment outcomes observed in Madang Province, Papua New Guinea
Toua, W., Lape, V., Bolnga, J. W., Daimen, M., Kelebi, T., Vaccher, S. J., & Greig, J. E. (2024) · Public Health Action · doi:10.5588/pha.24.0015 · Cited by 3
“21 Patient treatment support remains a challenge in PNG; however, education and counselling involving counsellors and peer counsellors contributed to high retention in care for DS and DR-TB in the very high-incidence setting of Daru, PNG. 22,23 While family members are not the preferred option for…”
BackgroundHusna, A. R., Nursalam, N., Hidayat, A. A. A., & Makhfudli, M. (2024) · Pacific Rim International Journal of Nursing Research · doi:10.60099/prijnr.2025.270467 · Cited by 5
Nyamagoud, S. B., Dsouza, P. D., Chitralu, S. P. P., Solankure, K. A., & Swamy, A. H. V. (2025) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2025.3434 · Cited by 1
Gao, G., Easton, A. V., Salerno, M. M., Angulo, M., Buchanan, C., Ingram, D. J., Humphrey, E., Whitehead, M., Robinson, E., Chuck, C., et al. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000898 · Cited by 1
da Silva, R. D., de Farias, E. R. G., da Graça, J. M. B., Pinheiro, E. M. N., & Cavalcante, E. F. D. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326784 · Cited by 1
Aidoo-Frimpong, G. A., Koku, E. F., Okoro, O. N., Gyamerah, A. O., Johnson, N., & Schwartz, S. (2025) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-025-01750-6 · Cited by 2
“…to care [22, 23]; long-acting injectable antipsychotics have improved medication adherence and reduced relapse in mental health treatment [24]; and the 3HP regimen for tuberculosis, administered weekly over three months, has demonstrated high completion rates compared to daily treatment [25].”
Gao, C., Li, F., Ding, W., Zhang, Y., Zhang, J., & Li, X. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092267 · Cited by 2
Sakala, D. Y., Tamuzi, J. L., Shumba, C. S., & Nyasulu, P. S. (2025) · Journal of Public Health in Africa · doi:10.4102/jphia.v16i4.1364 · Cited by 2
“16,18 The burden of TB in prisons in SSA is alarmingly high and has been compounded by factors such as overcrowding, high rates of HIV coinfection, inadequate healthcare infrastructure and poverty.”
Iem, V., Suthepmany, S., Inthavong, V., Sisouvanh, A., Choumlivong, K., Oh, K. H., du Cros, P., Sall, F. B., Merle, C. S., Sébert, J., et al. (2025) · Tropical Medicine & International Health · doi:10.1111/tmi.70041 · Cited by 1
Tian, M., Ding, H., Lü, P., Liu, Q., Ding, X., Pan, J., Zhu, L., & Yang, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-17061-7 · Cited by 1
“…real-time adherence monitoring through structured interventions—including reminder letters, telephone follow-ups, home visits and electronic pillboxes—supplemented by psychological support mechanisms such as counseling and peer-support networks to systematical enhance medication compliance 27,56 .”
InfluentialPerwitasari, D. A., Faridah, I. N., Casnan, C., Nurjanah, N., Listiana, I., Ristiono, H., & Ramadhani, J. (2025) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2025.101714 · Cited by 1
Wilandika, A., Rahmawati, E. Y., Yusof, S. B., & Handayani, P. (2025) · Journal of Public Health · doi:10.1093/pubmed/fdaf152 · Cited by 1
Renforcer l’éducation thérapeutique des patients tuberculeux
Perriot, J., Masson, M., & Peiffer, G. (2025) · La Revue de l Infirmière · doi:10.1016/j.revinf.2025.10.031 · Cited by 1
Medina-Marino, A., Arua, E., de Vos, L., Fiphaza, K., Bezuidenhout, D., Ngcelwane, N., Charalambous, S., & Daniels, J. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf714 · Cited by 2
“Despite investments in behavioral interventions to improve TB treatment outcomes, many are designed with a one-size-fits-all approach, assuming uniform patient behavior and support needs [10, 11].”
Shah, P., Zaidi, I., Adil, M., Gurav, J., Kutikuppala, L. V. S., Tummala, N., Sojitra, V., & Suvvari, T. K. (2025) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_65_25 · Cited by 1
Impact of Medication Adherence on Quality of Life in Tuberculosis Patients
Achmad, G. N. V., Husna, R. M., Priyandani, Y., & Zairina, E. (2025) · Research in Clinical Pharmacy · doi:10.59931/rcp.25.0011 · Cited by 2
Sordello, S., Brock, L., Tagliavini, A., Federico, D., Boulenc, X., Pergher, M., Huc‐Claustre, E., Metcalf, D., Walter, N. D., Robertson, G. T., et al. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01109-25 · Cited by 1
“The statistically significant impact of the weekend dosing holiday on the BALB/c mouse T90 for the 2RHZE/2RH treatment is consistent with analyses of clinical data indicating that the current rifampin-based regimen used worldwide has low forgiveness for non-adherence or missed doses (2, 4).”
Johnson, T. S., Nanziri, L., Meyer, A. J., Ggita, J. M., Armstrong-Hough, M. J., Ayakaka, I., Shenoi, S., Katamba, A., & Davis, J. L. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344250 · Cited by 8
钱淑银, Wang, X. R., Huang, B., Lu, H. J., Xu, C., & Shen, J. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1797748 · Cited by 1
Octavia, D. R., Hermansyah, A., Nita, Y., Asmani, F., & Abdullah, I. (2026) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/ipid/2070413 · Cited by 1
“Considering that patient compliance with treatment is one of the determining factors in the success of therapy, it is important to provide educational and counseling interventions to TB patients to prevent patient loss to follow-up [42, 43].”
Cummings, J. E., Woolhiser, L. K., Guglielmi, V. E., Romano, A., Pauly, S., Zimmerman, M., Kaya, F., Walter, N. D., Robertson, G. T., & Slayden, R. A. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01953-25 · Cited by 1
“These prolonged treatments contribute to poor patient adherence, treatment failure, and the development of additional drug resistance (5).”
Asante-Poku, A., Yeboah-Manu, M., Osei-Wusu, S., Asare, P. P. A., Boadu, A. A., Danso, E. K., Tetteh, P., Siam, I. M., Hayibor, K. M., Afum, T., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1826484 · Cited by 1
“Furthermore, inadequate information impairs medication adherence, thereby contributing to the emergence of TB strains resistant to available medications (6–8).”
Daramola, O., & Nyasulu, P. S. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-45002-1_35 · Cited by 2
Tuberculosis Treatment and Adherence
Story, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-66703-0_19 · Cited by 1
Stephanie, F., Saragih, M., Tambunan, U. S. F., & Siahaan, T. J. (2022) · Life · doi:10.3390/life12091333 · Cited by 1
Depression in Tuberculosis Patient: A literature Review
Aprilia, I. (2021) · Scientia Psychiatrica · doi:10.37275/scipsy.v4i1.108 · Cited by 2
Zenatti, G., Raviglione, M. C., Tesfaye, F., Bobosha, K., Björkman, P., & Walles, J. K. (2022) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2022.100344 · Cited by 2
Mangan, J. M., Burzynski, J. N., deCastro, B. R., Salerno, M. M., Lam, C. K., Macaraig, M., Reaves, M., Kiskadden-Bechtel, S., Bowers, S., Sathi, C., et al. (2023) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0583 · Cited by 1
Kristanti, A. W., Christanti, J., & Khadijah, N. (2023) · Jurnal Pranata Biomedika · doi:10.24167/jpb.v2i1.10102 · Cited by 1
“Ketidakberhasilan pengobatan disebabkan oleh ketidakpatuhan pasien selama berobat, mengingat waktu pengobatan TB yang panjang dan rejimen pengobatan TB rentan untuk resisten.(5,6) Kepatuhan pasien dalam pengobatan dapat dipengaruhi oleh beberapa faktor salah satunya pengetahuan.”
BackgroundJones, A. S. K., Horne, R., White, J., Costello, T., Darvell, M., Karat, A. S., Kielmann, K., Stagg, H. R., Hill, A. T., Kunst, H., et al. (2023) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2023.2277289 · Cited by 3
“Anti-tuberculosis treatment (ATT) can cure TB infection, however as regimens include multiple medicines to be taken generally for at least six months, poor adherence can occur (Alipanah et al., 2018; Munro et al., 2007).”
BackgroundResultHong, H. Y., Park, Y., Yong, S. H., Woo, A., Leem, A. Y., Lee, S. H., Chung, K. S., Lee, S. H., Kim, S. Y., Kim, E. Y., et al. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e4 · Cited by 1
Syarifah, S., & Santi, D. N. (2023) · Journal of Public Health in Africa · doi:10.4081/jphia.2023.2675 · Cited by 3
Medication Management Application for Directly Observed Treatment of TB Patients
Tania, M. H., Rahman, M. A., & Ahmed, K. U. (2024) · International Conference on Electrical Engineering and Information Communication Technology · doi:10.1109/iceeict62016.2024.10534459 · Cited by 1
“The implementation of DOT differs based on resource availability, cultural influences, and individual healthcare provider perspectives, often resulting in incomplete adherence, even in populations where strict compliance is crucial [11], [12].”
BackgroundNagaraja, S. B., Menon, S., Balakrishnan, R., Hombaiah, C., Reddy, R. H. R., & Anil, S. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101655 · Cited by 1
Validação do aplicativo móvel TBApp para a gestão do autocuidado de pessoas com tuberculose
de Assis, L. B. D. O., da Silva, D. M. G. V., da Silva, J. M., dos Santos, E. R., Pinheiro, J. D. S., Sacramento, D. S., de Oliveira, H. J. H., & Sicsú, A. N. (2024) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2023-0195pt · Cited by 1
Ogbuabor, D. C., Okorie, O., & Ghasi, N. C. (2024) · SSM - Health Systems · doi:10.1016/j.ssmhs.2024.100019 · Cited by 1
Design of RNA Polymerase Inhibitors as Therapeutics for Tuberculous Meningitis
Vummidi, V., & Talluri, S. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265341228240827062721 · Cited by 1
Phiri, D., Chimfwembe, K., Namfukwe, B. M. W., & Changwe, S. B. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24oct005 · Cited by 1
Jops, P., Cowan, J., Trumb, R. N., Kupul, M., Kuma, A., Bell, S. A., Keam, T., Bauri, M., Nindil, H., Majumdar, S. S., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002572 · Cited by 1
Melis, E. J., van den Bemt, B. J. F., Schrander, D. E., & Vriezekolk, J. E. (2024) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2024-004328 · Cited by 1
“23 Practical problems were among the most impactful DRPs.”
Ardana, M., Laksitorini, M. D., Lukitaningsih, E., & Nugroho, A. E. (2024) · Current Drug Metabolism · doi:10.2174/0113892002361205250123101231 · Cited by 1
Sukartini, T., Hidayati, L., & Pratiwi, I. N. (2019) · Dharmakarya · doi:10.24198/dharmakarya.v8i3.19156 · Cited by 1
Effects of the Covid-19 Pandemic on "The Big Three": Hiv, Tuberculosis, and Malaria
May, M. (2020) · Annals of Public Health Reports · doi:10.36959/856/503
Pinto, E. S., & Carneiro, R. T. D. O. (2020) · Textura · doi:10.22479/texturav14n1p121-130 · Cited by 1
Pradani, F. Y., Nurindra, R. W., & Usman, U. (2021) · Insights in Public Health Journal · doi:10.20884/1.iphj.2020.1.2.3779 · Cited by 1
Nofitasari, A., Nawawi, N., Yati, M., & Yunam, S. S. (2020) · INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD) · doi:10.36566/ijhsrd/vol2.iss2/31 · Cited by 1
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Bothamley, G. H. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10026118 · Cited by 1
Katana, G. G., Ngari, M. M., Maina, T. W., Sanga, D., & Abdullahi, O. A. (2021) · Research Square · doi:10.21203/rs.3.rs-966867/v1 · Cited by 1
Sekandi, J. N., Shi, W., Zhu, R., Kaggwa, P., Mwebaze, E., & Li, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4074672 · Cited by 1
Liu, X., Thompson, J. A., Dong, H., Sweeney, S., Li, X., Yuan, Y., Wang, X., He, W., Thomas, B. V., Xu, C., et al. (2023) · medRxiv · doi:10.1101/2023.01.25.23285001 · Cited by 1
“Digital adherence technologies including short message service (SMS) and electronic pill boxes, which support patients in their adherence, have the potential of enhancing patient care through improving interactions between patients and health care providers, and increasing treatment adherence and successful treatment…”
BackgroundRyuk, D. K., Pelissari, D. M., Alves, K. B. A., Oliveira, P. B., Castro, M. C., Cohen, T., Sanchez, M. N., & Menzies, N. A. (2024) · medRxiv · doi:10.1101/2024.01.05.24300846 · Cited by 1
Sordello, S., Brock, L., Tagliavini, A., Federico, D., Boulenc, X., Pergher, M., Huc‐Claustre, E., Metcalf, D., Walter, N. D., Robertson, G. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.07.668704 · Cited by 1
“However, it is likely that new regimens will remain quite lengthy, despite the inclusion of new drugs to maximize efficacy and reduce the risk of resistance [2, 8, 9].”
Marino, A. M., Arua, E., de Vos, L., Fiphaza, K., Bezuidenhout, D., Ngcelwane, N., Charalambous, S., & Daniels, J. (2025) · medRxiv · doi:10.1101/2025.09.04.25335036 · Cited by 1
Tuberculosis: So much accomplished and so much more to be done
Gupta, A. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_924_2026 · Cited by 1
“15 Thus, medication adherence was challenging, and development of further drug resistance and high rates of morbidity and mortality often resulted.”
Factors associated with the development of drug resistant tuberculosis in Ethiopia
Keto, H. B. (2020) · Unisa Institutional Repository (University of South Africa)
Risk Factors of Drop-Out among Tuberculosis Patients in Semarang: A Case-Control Study
Handayani, S. W., Wilson, D. C., Utami, M. N., Manglapy, Y. M., Suharyo, S., & Hinchcliff, R. (2021) · doi:10.36295/asro.2021.24157
“found that family member DOT was associated with a lower rate of adherence, and a higher rate of treatment failure compared to trained health worker(9).”
ResultTuberculose e migrações interna e internacional no estado de São Paulo: semelhanças e contrastes
Pinto, P. F. P. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2020.tde-09032021-161952
Treatment adherence to tuberculosis: What works
Chinnadurai, A. (2020) · The National Medical Journal of India · doi:10.4103/0970-258x.317477
Determinants of tuberculosis treatment outcomes in Asia and Africa
Yuliyani, Y., & Sartika, R. A. D. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5n3.1666 · Cited by 1
“Low adherence increases the risk of poor treatment outcomes, including treatment failure, recurrence, and development or strengthening of drug resistance (Alipanah et al., 2018).”
Background(2022) · Journal of Social Science and Humanities · doi:10.53469/jssh.2022.4(02).05
Rao, J. S., Diwan, V., Kumar, A. A., Varghese, S. S., Sharma, U., Purohit, M. R., Das, A., & Rodrigues, R. (2022) · doi:10.2196/preprints.38143
Gao, L., Xin, H., Zhang, H., Cao, X., Feng, B., Quan, Z., Du, Y., He, Y., Wang, D., Zhang, B., et al. (2020) · doi:10.21203/rs.3.rs-92812/v1
“The summarized results showed that around halves of TB patients were treated by self-administration (52%) and that only 20% actually had their treatment observed by healthcare workers [16].”
ResultRen, J., Han, D., Zhang, J., Wang, Y., Huang, Q., Tian, T., & Li, X. (2020) · doi:10.21203/rs.3.rs-50573/v1
Sookaromdee, P., & Wiwanitkit, V. (2020) · Liaquat National Journal of Primary Care · doi:10.37184/lnjpc.2707-3521.1.17
Dessie, G., Wagnew, F., Amare, D., Zeleke, B., Negesse, A., Mulugeta, H., Abebaw, B., Haile, D., & Habtewold, T. D. (2019) · doi:10.21203/rs.2.10099/v2
Usov, K. (2022) · Scientific Papers Collection of the Angarsk State Technical University · doi:10.36629/2686-7788-2022-1-234-237
da Silva, K. N., dos Santos, P. S. P., Barbosa, R. D. S., Lopes, M. D. S. V., Pinto, A. G. A., & Cavalcante, E. G. R. (2022) · Revista da Escola de Enfermagem da USP · doi:10.1590/1980-220x-reeusp-2021-0433pt
Family directly observed therapy for children with drug-resistant TB
Rekart, M. L., Morshed, T., Mulanda, W. K., Klieascikova, J., Sitali, N., Rajabzoda, A., Avzamova, S., Pirmahmadzoda, B., Aung, A., Sayfulloev, M., et al. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0168
Improving treatment adherence and outcome among TB patients under daily regimen - The way forward
John, A., Swaminathan, S. S., & Avirneni, H. T. (2022) · Journal of Dr. YSR University of Health Sciences. · doi:10.4103/jdrntruhs.jdrntruhs_78_21
Understanding emergence of antimycobacterial dose dependent resistancePreprint
Kloprogge, F., Canseco, J. O., Phee, L. M., Sadouki, Z., Kipper, K., Witney, A. A., Stoker, N. G., & McHugh, T. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.02.506358
RESÍDUOS DE LUVAS DE LÁTEX: PERCEPÇÃO DE RISCOS SEGUNDO GRADUANDOS DE ENFERMAGEM
Mendes, A. A., & Herculano, R. D. (2022) · doi:10.22533/at.ed.66222200926
Maia, J. C., Bim, L. L., Rédua, H. H. C. B., de Figueiredo, T., Orloski, T. D. F. W., do Amaral, C. R. M., Dias, R. D. C. M., & Vieira, A. C. F. G. C. (2022) · doi:10.22533/at.ed.66222200911
de Andrade, M. I., do Lago, P. N., Fernandes, A. D. S., dos Santos, C. R., Bessas, D. E. C., Arcebispo, C. D. O., Duarte, M. E. L., Santos, A. L. L., da Silva, E. N., Campos, E. D. C., et al. (2022) · doi:10.22533/at.ed.66222200921
IMPLICAÇÕES NA SAÚDE DOCENTE: UM ENSAIO SOBRE OS PRINCIPAIS RISCOS DO TRABALHO
Figueira, L. R., de Souza, J. B., & Costa, M. A. R. (2022) · doi:10.22533/at.ed.66222200912
Cardoso, A. S. D. E. S., & Carvalho, R. G. (2022) · doi:10.22533/at.ed.66222200925
FILA DE ESPERA COMO OPORTUNIDADE PARA EDUCAÇÃO EM SAÚDE SOBRE AUTISMO: RELATO DE EXPERIÊNCIA
Silva, J. D., de Souza, G. R., Brito, L. C. D. S., Rocha, D. M. A., Fernandes, M. A. M., Gadelha, E. A., Araújo, K. R. M., Braga, S. T., Gomes, S. C., CARVALHO, C. G., et al. (2022) · doi:10.22533/at.ed.66222200910
O ENFERMEIRO NA PREVENÇÃO E RASTREAMENTO DO CÂNCER DE COLO DE ÚTERO NA ATENÇÃO PRIMÁRIA
Santana, R. D. S., Carvalho, W. L., de Oliveira, C. C. M., Ramos, W. L. B. E., Mendes, G. S., Lima, A. C. S., Gonçalves, M. M. C., Ximenes, B. C. S., Coelho, M. V. G. A., de Oliveira, L. F., et al. (2022) · doi:10.22533/at.ed.66222200916
Nicoletti, G. S., Ilha, S., Nazário, E. G., Vissotto, C. T., Machado, K. D. F. C., Rangel, R. F., & Munhoz, O. L. (2022) · doi:10.22533/at.ed.66222200923
O SISTEMA RENINA-ANGIOTENSINA-ALDOSTERONA E SUA ATUAÇÃO NA HIPOTENSÃO POR PERDA VOLÊMICA
Pschisky, A., & Cardoso, D. T. G. (2022) · doi:10.22533/at.ed.66222200919
Fuadiati, L. L., Sukartini, T., & Makhfudli, M. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11050
Macdonald, S. H.-F., France, N. F., Hodgson, I. J., Ali, F., Dewi, C., Abdurrakhman, I., Runtu, Y. M., Juan, A., Sugiharto, J., Byrne, E., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3181385/v1
A Meta-analysis of Studies on the Therapeutic Effects of Digital Therapies (Preprint)Preprint
Seo, Y. C., Yong, S. Y., & Kim, S. H. (2023) · doi:10.2196/preprints.51079
Kerschberger, B., Daka, M., Shongwe, B., Dlamini, T., Ngwenya, S., Danbakli, C., Mamba, B. B., Nxumalo, B., Sibanda, J., Dube, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3135109/v1
Special Issue “Drug Candidates for the Treatment of Infectious Diseases”
Chin, C. M., & dos Santos, J. L. (2023) · Pharmaceuticals · doi:10.3390/ph16091257
“Contemporary obstacles, such as the rise of resistance [6–8], the presence of severe adverse effects without adequate safety, subpar effectiveness, therapy non-adherence [9], and limited access to healthcare services, stand as barriers that must be surmounted.”
Conocimientos sobre tuberculosis en trabajadores de la salud del departamento del Cauca, Colombia
Polanco-Pasaje, J. E., Benjumea‐Bedoya, D., & del Corral, H. (2023) · Hacia la Promoción de la Salud · doi:10.17151/hpsal.2023.28.1.6
“Además, se ha visto que una adecuada educación y asesoramiento a los pacientes por parte del personal de salud mejora la adherencia al tratamiento y se asocia con buenas prácticas de control y prevención de la infección (28,29).”
BackgroundSOWANS E-TB Application Innovation on Quality of Life and Medication Compliance in MDR-TB Patients
Saleh, A., Condeng, B., & Nuzul, S. M. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44i4.1366
“Of all districts/cities in Central Sulawesi Province, the highest TB cases were found in Palu City with 693 cases (Alipanah et al., 2018).”
BackgroundTreatment Determinants Influence the Health of Tuberculosis Patients
Pratiwi, D., Nyorong, M., Efendy, I., Anggraini, I., & Nadapdap, T. P. (2022) · Jurnal Perilaku Kesehatan Terpadu · doi:10.61963/jpkt.v1i1.16
“Patient compliance with therapy is one of the criteria of successful TB therapy management (Alipanah et al., 2018; Lan et al., 2020; Ahmad et al., 2018).”
BackgroundChapitre 5: Le traitement de la tuberculose active
Johnston, J. C., Cooper, R. D., & Menzies, D. (2023) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2023.2226003
“1,37 Les incitatifs et les mesures facilitatrices peuvent aussi atténuer la marginalisation sociale et économique d’une personne.”
BackgroundHendra, G. A., Susanto, F. H., & Choirunniza, A. N. (2023) · JIFFK Jurnal Ilmu Farmasi dan Farmasi Klinik · doi:10.31942/jiffk.v20i2.8380
Mantari Palomino, L. M. (2023) · Universidad Privada San Juan Bautista · doi:10.59590/upsjb/fcs.med.hum/tesis/4462
Fahrudda, A., & Kusbaryanto, K. (2023) · Public Health and Preventive Medicine Archive · doi:10.53638/phpma.2023.v11.i1.p09
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y., Wang, X., Wang, X.-L., Sun, M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235081
Serina, P. T., Bounds, M., Dandapani, H. G., Carnes, T. C., Linnebur, S. A., Picazo, J. G., Keene, S. E., & Goldberg, E. M. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18932 · Cited by 2
Video observed therapy (VOT) for people with tuberculosis (TB): a scoping review
Thinh, A. D., Morgan, E., Pereira, K., Khosa, C., & Wingfield, T. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-03049-8 · Cited by 2
Determinants Associated with Treatment Discontinuation in Tacna Health Network Tuberculosis Patients
Tenorio, A. E. T., Cruz, K. M. L.-D. L., Bahamondes, R., Valle, L. A. M. D., Choy, A. H. K., Cardenas-Rueda, P., & Tozo-Burgos, J. G. (2024) · Lecture notes in networks and systems · doi:10.1007/978-3-031-60218-4_19
Metadata
- Authors
- Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P.
- Affiliations
- University of California, San Francisco (US)
- World Health Organization (CH)
- Corresponding author
- Nahid, Payam
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-07-03
- Volume
- 15
- Issue
- 7
- Pages
- e1002595
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6029765
- OpenAlex
- W2810683857
- Cited by
- 503
- References
- 156
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 79 · 2023: 88 · 2022: 75 · 2021: 67 · 2020: 42 · 2019: 26 · 2018: 3
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (publishedVersion)
- eScholarship (California Digital Library) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- tuberculosis, medication adherence, directly observed therapy, drug-resistant tuberculosis, self-administered therapy, sputum smear conversion, treatment failure, drug resistance development, incentives, patient education, video-observed therapy, mobile phone reminders, treatment success, relapse, transmission risk, multidrug therapy, patient-provider relationship
- MeSH terms
- Adolescent, Adult, Antitubercular Agents, Attitude of Health Personnel, Child, Child, Preschool, Health Personnel, Humans, Infant, Infant, Newborn, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Risk Factors, Self Care, Tuberculosis, Video Recording, Randomized Controlled Trials as Topic, Treatment Outcome, Telemedicine, Directly Observed Therapy, Cell Phone, Medication Adherence, Text Messaging, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.